A review study done by Katharia et al. [ 8] showed that pentraxin-3 might be used as biomarker in the diagnosis of periodontal disease; besides, it might have clinical implication in diagnosing the “at site” inflammatory status of periodontal disease. The gene discussed is PTX3; the disease is periodontal disorder.